Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy

Abstract excerpt

DNA is the well-known molecular target of current platinum-based anticancer drugs; consequently, their clinical use is severely restricted by their systemic toxicities and drug resistance originating from non-selective DNA damage. Various strategies have been developed to circumvent the shortcomings of platinum-based chemotherapy but the inherent problem remains unsolved. Here we report that platinum pyrithione...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Metal complexes synthesis and properties
• Share to Peptidase Inhibition and Analysis
• Share to Ubiquitin and proteasome pathways